{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:24:34Z","timestamp":1791930274720,"version":"4.3.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2001,5,1]],"date-time":"2001-05-01T00:00:00Z","timestamp":988675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2001,5]]},"DOI":"10.1067\/mpd.2001.111331","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T04:21:43Z","timestamp":1027570903000},"page":"728-734","source":"Crossref","is-referenced-by-count":395,"title":["A randomized trial of treatment for multisystem Langerhans\u2019 cell histiocytosis"],"prefix":"10.1067","volume":"138","author":[{"given":"Helmut","family":"Gadner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Grois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Arico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Broadbent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Ceci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ake","family":"Jakobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Komp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Michaelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"P\u00f6tschger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Pritchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Ladisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1067\/mpd.2001.111331_bib1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0889-8588(05)70507-4","article-title":"Nosology and pathology of Langerhans cell histiocytosis","volume":"12","author":"Schmitz","year":"1998","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1067\/mpd.2001.111331_bib2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJM199407213310303","article-title":"Langerhans\u2019 cell histiocytosis (histiocytosis X)\u2014a clonal proliferative disease","volume":"331","author":"Willman","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1067\/mpd.2001.111331_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3476(95)70248-2","article-title":"Langerhans cell histiocytosis","volume":"127","author":"Egeler","year":"1995","journal-title":"J Pediatr"},{"key":"10.1067\/mpd.2001.111331_bib4","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1002\/(SICI)1097-0142(19990515)85:10<2278::AID-CNCR25>3.0.CO;2-U","article-title":"Langerhans cell histiocytosis: diagnosis, natural history, management, and outcome","volume":"85","author":"Howarth","year":"1999","journal-title":"Cancer"},{"key":"10.1067\/mpd.2001.111331_bib5","first-page":"615","article-title":"The histiocytoses","author":"Ladisch","year":"1997"},{"key":"10.1067\/mpd.2001.111331_bib6","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0022-3476(75)80576-2","article-title":"Histiocytosis X\u2014an analysis of prognostic factors","volume":"87","author":"Lahey","year":"1975","journal-title":"J Pediatr"},{"key":"10.1067\/mpd.2001.111331_bib7","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/1097-0142(19810215)47:4<798::AID-CNCR2820470427>3.0.CO;2-J","article-title":"A staging system for histiocytosis X: a southwest oncology group study","volume":"47","author":"Komp","year":"1981","journal-title":"Cancer"},{"key":"10.1067\/mpd.2001.111331_bib8","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/mpo.2950230203","article-title":"Treatment strategy for disseminated Langerhans cell histiocytosis","volume":"23","author":"Gadner","year":"1994","journal-title":"Med Pediatr Oncol"},{"key":"10.1067\/mpd.2001.111331_bib9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1136\/adc.65.3.301","article-title":"Langerhans cell histiocytosis: the case for conservative treatment","volume":"65","author":"McLelland","year":"1990","journal-title":"Arch Dis Child"},{"issue":"Suppl XXIII","key":"10.1067\/mpd.2001.111331_bib10","first-page":"541","article-title":"Treatment of LCH- evolution and current approaches","volume":"70","author":"Ladisch","year":"1994","journal-title":"Br J Cancer"},{"key":"10.1067\/mpd.2001.111331_bib11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/mpo.2950170205","article-title":"Etoposide (VP16) in the treatment of multisystem Langerhans cell histiocytosis (histiocytosis X)","volume":"17","author":"Broadbent","year":"1989","journal-title":"Med Pediatr Oncol"},{"key":"10.1067\/mpd.2001.111331_bib12","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1002\/1097-0142(19881215)62:12<2528::AID-CNCR2820621213>3.0.CO;2-#","article-title":"Etoposide in recurrent childhood Langerhans cell histiocytosis: an Italian cooperative study","volume":"62","author":"Ceci","year":"1988","journal-title":"Cancer"},{"key":"10.1067\/mpd.2001.111331_bib13","first-page":"573","article-title":"Response to therapy in multisystem Langerhans cell histiocytosis (LCH). Results from the DAL HX-83 and DAL HX-90 studies [abstract]","volume":"27","author":"Grois","year":"1996","journal-title":"Med Pediatr Oncol"},{"key":"10.1067\/mpd.2001.111331_bib14","first-page":"208-2","article-title":"Histiocytosis syndromes in children","volume":"1","author":"Chu","year":"1987","journal-title":"Lancet"},{"key":"10.1067\/mpd.2001.111331_bib15","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/mpo.2950170527","article-title":"Histiocytosis syndromes in children. II. Approach to the clinical and laboratory evaluation of children with Langerhans cell histiocytosis","volume":"17","author":"Broadbent","year":"1989","journal-title":"Med Pediatr Oncol"},{"key":"10.1067\/mpd.2001.111331_bib16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/mpo.2950230207","article-title":"LCH-I: a randomized trial of etoposide versus vinblastine in disseminated Langerhans cell histiocytosis","volume":"23","author":"Ladisch","year":"1994","journal-title":"Med Pediatr Oncol"},{"key":"10.1067\/mpd.2001.111331_bib17","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/bmj.304.6832.951","article-title":"Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer","volume":"304","author":"Hawkins","year":"1992","journal-title":"Br Med J"},{"key":"10.1067\/mpd.2001.111331_bib18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/mpo.2950230202","article-title":"Langerhans cell histiocytosis and etoposide: risk vs benefits [editorial]","volume":"23","author":"D\u2019Angio","year":"1994","journal-title":"Med Pediatr Onocol"},{"key":"10.1067\/mpd.2001.111331_bib19","series-title":"Analyzing survival data from clinical trials and observational studies","author":"Marubuni","year":"1997"},{"key":"10.1067\/mpd.2001.111331_bib20","first-page":"1905","article-title":"Statistical principles for clinical trials. ICH harmonised tripartite guideline","volume":"18","author":"ICH E9","year":"1999","journal-title":"Stat Med"},{"key":"10.1067\/mpd.2001.111331_bib21","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0889-8588(05)70511-6","article-title":"Central nervous system disease in Langerhans cell histiocytosis","volume":"12","author":"Grois","year":"1998","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1067\/mpd.2001.111331_bib22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/(SICI)1096-911X(199704)28:4<289::AID-MPO8>3.0.CO;2-E","article-title":"Diabetes insipidus associated with Langerhans cell histiocytosis: is it reversible?","volume":"28","author":"Broadbent","year":"1997","journal-title":"Med Pediatr Onocol"},{"key":"10.1067\/mpd.2001.111331_bib23","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/BF01956429","article-title":"VP-16 and the treatment of histiocytosis [letter]","volume":"153","author":"Gadner","year":"1994","journal-title":"Eur J Pediatr"},{"key":"10.1067\/mpd.2001.111331_bib24","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3109\/08880019409141688","article-title":"Increased risk of secondary leukemia after single-agent treatment with etoposide for Langerhans cell histiocytosis","volume":"11","author":"Haupt","year":"1994","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1067\/mpd.2001.111331_bib25","first-page":"3310","article-title":"Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90","volume":"95","author":"Schrappe","year":"2000","journal-title":"Blood"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347601073255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347601073255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T11:52:57Z","timestamp":1557402777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347601073255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,5]]}},"alternative-id":["S0022347601073255"],"URL":"https:\/\/doi.org\/10.1067\/mpd.2001.111331","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2001,5]]}}}